Med BioGene Inc. (TSXV:MBI) announced a non-brokered private placement of 2,000,000 shares at CAD 0.05 per share for gross proceeds of CAD 100,000 with existing investor Weir-Jones Engineering Consultants Ltd. on January 7, 2021. The transaction is subject to approval from TSX Venture Exchange. All shares to be issued are subject to a hold period of four months from the date of issuance.